VirD™ Functional Membrane Protein Array

420+ Unique Proteins for Drug Development

VirD™ membrane protein arrays use a patented system to synthesize important drug targets with proper folding and function.

REQUEST INFO

Correctly-folded, Membrane-embedded Functional Proteins

VirD contains 420+ unique proteins and is useful for drug development and functional assays

G protein-coupled receptors (GPCRs) play critical roles in a wide variety of physiological processes, and mutations in GPCRs are implicated in many diseases. GPCR receptors must be embedded in a cell membrane to fold correctly and are difficult to express in traditional recombinant expression systems. The most common method used to study GPCRs is to overexpress them in transfected mammalian cell lines. However, the transfected cells also contain endogenous receptors, making it a challenge to interpret experimental results.

Our VirD viral-based expression technology expresses individual GPCR proteins embedded in a cell membrane. Purified virions displaying correctly-folded GPCRs are printed onto glass to create VirD arrays. This method eliminates the problem of endogenous receptor competition when using traditional methods, and yields much cleaner data. VirD GPCR arrays can be purchased directly or provided as a complete analysis service.

VirD Membrane Protein Array Validation and Production

VirD is a microarray that uses virions to display functional membrane proteins like GPCRs and is useful for drug development and functional assays.

VirD Membrane Protein Array Validation and Production Figure

VirD Membrane Protein Array Methods and Analysis

VirD is a sensitive membrane protein matrix platform that provides quantitative binding interaction data from a few microliters of sample. VirD can help identify the function of orphan GPCRs and can be used to develop new drugs targeting membrane proteins and receptors.

VirD Membrane Protein Array Methods and Analysis Figure


VirD™ Service at CDI Labs

Technical Details

To create the VirD array, 500+ unique human membrane protein open reading frames (ORFs) are modified to remove their stop codons and subcloned into the UL27 locus of the herpes simplex (HSV-1) virus genome with a C-terminal v5 tag. These individually engineered viron clones are then used to infect mammalian cells. Native human protein assembly machinery correctly folds the proteins and shuttles them to the viral membrane. Membrane-protein bearing VirD virions are concentrated from culture supernatants and their membrane-protein expression confirmed via anti-V5 immunoblots.

Purified virions were then printed on SuperEpoxy glass slides to create the final GPCR-VirD arrays. The quality of printed VirD-GPCR arrays is confirmed via staining for HSV-1 Glycoprotein D (gD) via anti-gD antibody and comparing those as compared with bovine serum albumin negative controls (BSA).

Service Details and Data Deliverables

A simple antibody interaction VirD service involves drug candidate antibodies diluted and reacted with individual microarrays with BSA blocking. After incubation, samples are stained for one or two desired fluorescent secondary detection antibodies (i.e., IgG1). Arrays are scanned and raw TIF images are created using Molecular Devices Genepix microarray scanners. Spots are then aligned to CDI library (.gal) files, and spot readings are output as raw Genepix results (.gpr) files. These raw results are then delivered both as .gpr files and combined output data tables.

Sample Requirements

Antibody isolates10 μg per sample (concentration 0.1 mg/mL)
Protein / peptide / small molecule10 μg per sample (concentration 0.1 mg/mL)
RNA1 mL per sample (concentratiion 2 μM)
Other fluids> Please contact us
Note

Human serum or plasma often contains anti-HSV-1 antibodies making VirD inappropriate for clinical studies.

Sample Shipping and Sample Return

We will include shipping details in your quote – you must cover the cost of shipping samples to CDI Labs. Typically, after you receive your report, CDI Labs keeps the remaining samples for two months and then disposes of them. When shipping to us, please let us know if you want the remaining samples returned after the study is complete. Return shipping will be charged.

Customer Testimonial

"We enjoyed working with CDI Labs. We used both VirScan and HuScan services from CDI Labs as part of our neurodegenerative disease research. The team at CDI Labs was very responsive and great to work with, and they went above and beyond to get us our results very quickly. They were particularly helpful in making contract arrangements and ensuring that everything was in place for a smooth collaboration. CDI Labs also provided a comprehensive statistical analysis, which will be invaluable as we build on our research. We’re still analyzing the data, but we’re confident that we’ll gain new insights into disease mechanisms that will advance our research."

Wouter Peelaerts, PhDProfessor, KU Leuven

Customer Testimonial

"CDI Labs provide consistent service and consistently high-quality protein array products to our lab. Their sales and scientific team are courteous and timely in their responses to our queries.”

Dr. Andrew McKeonMayo Clinic College of Medicine & Science

Data and technology validated by scientists

"We elected to use the HuProt Microarray because it is an extensive platform that contains over 21,000 unique, individually purified full-length human proteins and protein isoforms in duplicate, covering more than 81% of the proteome."

OncologistSchool of Medicine Research (as mentioned in "Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade" - AACR Clinical Caner Research - September 2022)

Data and technology validated by scientists

"This (VirScan) assay, which uses phage display immunoprecipitation and sequencing, is a sensitive and focused high-comprehensive approach that enables thorough serological profiling of antiviral antibodies in humans and, consequently, the identification of viral exposure throughout the human virome."

Faculty of MedicineResearch Institution (as mentioned in "Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC" - Science Advances - November 2023)

Data and technology validated by scientists

"By using (HuProt) protein arrays, we were able to evaluate a broader range of antigens compared to previous investigations."

Senior ScientistBiotech Research (poster presentation at the San Antonio Breast Cancer Symposium 2023)